Advertisement Morpholine Bioisosteres for Drug Design - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More


Morpholine Bioisosteres for Drug Design

More than 20 FDA-approved drugs contain the morpholine moiety, although it is often metabolically labile. Morpholine-based analogues may advantageously alter important pharmacokinetic properties such as lipophilicity and metabolic stability when grafted onto molecular scaffolds. Herein we have designed and synthesized a library of morpholine analogues for drug design.

We offer:

>100 unique morpholine analogues on a 5-50 g scale from stock.

Please visit our webpage to see Morpholine Bioisosteres, which we offer.